Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial

BACKGROUND: Androgenetic alopecia (AGA) is the most common hair loss disorder seen in men. It can have an early onset but has also been associated with ageing and senescence. It often induces pronounced psychological impact. ALRV5XR, a new hair loss treatment herein evaluated, was designed to target...

Descripción completa

Detalles Bibliográficos
Autores principales: Feldman, Peter R, Fiebig, Klaus M, Piwko, Charles, Mints, Boris M, Brown, Dennis, Cahan, Deborah J, Guevara-Aguirre, Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435693/
https://www.ncbi.nlm.nih.gov/pubmed/34541479
http://dx.doi.org/10.1016/j.eclinm.2021.101124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435693/
https://www.ncbi.nlm.nih.gov/pubmed/34541479
http://dx.doi.org/10.1016/j.eclinm.2021.101124

Ejemplares similares